Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Abhishek D., Galluzzi, Lorenzo, Apetoh, Lionel, Baert, Thais, Birge, Raymond B., Bravo-San Pedro, José Manuel, Breckpot, Karine, Brough, David, Chaurio, Ricardo, Cirone, Mara, Coosemans, An, Coulie, Pierre G., De Ruysscher, Dirk, Dini, Luciana, de Witte, Peter, Dudek-Peric, Aleksandra M., Faggioni, Alberto, Fucikova, Jitka, Gaipl, Udo S., Golab, Jakub, Gougeon, Marie-Lise, Hamblin, Michael R., Hemminki, Akseli, Herrmann, Martin, Hodge, James W., Kepp, Oliver, Kroemer, Guido, Krysko, Dmitri V., Land, Walter G., Madeo, Frank, Manfredi, Angelo A., Mattarollo, Stephen R., Maueroder, Christian, Merendino, Nicolò, Multhoff, Gabriele, Pabst, Thomas, Ricci, Jean-Ehrland, Riganti, Chiara, Romano, Erminia, Rufo, Nicole, Smyth, Mark J., Sonnemann, Jürgen, Spisek, Radek, Stagg, John, Vacchelli, Erika, Vandenabeele, Peter, Vandenberk, Lien, Van den Eynde, Benoit J., Van Gool, Stefaan, Velotti, Francesca, Zitvogel, Laurence, Agostinis, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653610/
https://www.ncbi.nlm.nih.gov/pubmed/26635802
http://dx.doi.org/10.3389/fimmu.2015.00588

Ejemplares similares

Ejemplares similares